Academic detailing

Academic detailing is interactive educational outreach that delivers evidence-based, unbiased training directly to outpatient clinicians in their own practice settings. Our clinical educators – pharmacists, nurse practitioners, physician assistants and physicians – meet one-on-one with practitioners to present the latest research and best practices on key actionable issues related to optimal prescribing. Whether focusing on reducing hospital readmissions for patients with COPD or improving the treatment of chronic pain, insomnia, and other common challenges faced by frontline clinicians, our partners rely on us to enhance patient outcomes through informed clinical decision-making. By synthesizing and condensing the most relevant and recent medical literature into accessible, non-commercial educational materials and delivering them through personalized outreach, Alosa Health helps clinicians make optimal treatment choices that improve care quality while avoiding unnecessary expenditures.

“Alosa has provided education to OSF providers for several years regarding managing chronic pain and treating opiate use disorder with buprenorphine. Kelly has been excellent in being accessible for these trainings, communicating in a prompt manner, and being willing to provide education to various primary care offices. Our providers have been very complimentary regarding the quality of the information and the materials provided. “
– Jennifer Wenger, LCSW Substance Use Services Program Manager, Behavioral Health, OSF HealthCare, Illinois

Academic Detailing Training

Using both distance learning and in-person training, we can develop a curriculum targeted to our partner’s specific goals. We will educate their team on the principles and execution of academic detailing programs and prepare them to deliver clear, actionable, evidence-based recommendations using social marketing techniques to achieve clinical behavior change.

Our academic detailer training equips detailers with social marketing techniques to “market the evidence” that improves prescriber decision-making.

“I am impressed by your training! It is engaging, interesting, professional, and relevant. I have learned so much. It is hands down the best training I have attended.”
– Janet Nelson, Strategic Prevention Framework for Prescription Drugs Project Director, Iowa Department of Health and Human Services 

Academic Detailing Programs

Alosa Health has considerable experience in sourcing, training, managing, and evaluating a strategic academic detailing program. We use Salesforce and mapping software Utilizing the most rigorous evidence-based materials, our specially trained clinical educators “market the evidence” to clinicians. The outreach is interactive, actionable and has been proven effective during its decades of use to improve clinical decision making.

Evidence Synthesis

Alosa Health’s team of clinical and research advisors conducts thorough reviews of the latest medication-related literature and data, and then condense it into unbiased, accessible, and user-friendly educational materials tailored to the needs of busy and often overworked healthcare decision-makers. We also offer customized material development to meet specific clinical needs of our partners, ensuring relevance and practical application in diverse healthcare settings.

Alosa’s clinical topics cover the most common and pressing clinical challenges front-line clinicians face every day.

“I am seeing more and more patients in my practice with dementia and having Alosa Health as a resource to learn about the latest information on how to navigate resources and manage this disease has been a great help. I keep the tear-off pad available, and caregivers are always in search of resources to help fill in the gap because it gets tough. I always welcome the visits and insight!”
– Dr. Emmanuel U. Agoh, MD, Houston, Texas 

Medication policy: Evidence analysis and outreach

Members of the Alosa team and our affiliated colleagues have years of experience analyzing the relation between patterns of medication use, outcomes, and cost in relation to drug policies at the state, federal, and health system levels. Just as we use our expertise to evaluate claims and counterclaims related to specific medications, we also critically evaluate the data on issues of drug approval, charges, costs, reimbursement policies, and their impact on patients and payors. We can then devise evidence-based recommendations for policy and system-based changes to improve access by patients to the prescription drugs that are the most clinically appropriate and affordable. Those insights can then be “marketed” through proactive educational outreach to key decisionmakers and policymakers to inform their work, parallel to our use of educational outreach to clinicians to offer them the most current, unbiased information about medication effects.

Work by our affiliated colleagues in these areas includes:

• defining the drivers of medication prices.
• assisting state-level Prescription Drug Affordability Boards.
• evaluating the role of cost-effectiveness analysis in determining fair charges for drugs.
• understanding the role of patents and other federal mechanisms in influencing medication costs.
• devising ways to improve the work of federal agencies that approve new medications and shape their reimbursement.
• integrating the evidence on effective policy interventions throughout the health care system that have been shown to improve the quality and affordability of medication use at the macro level.

Clinical Education Advising

Our team has decades of experience evaluating research, prescribing data, and creating concise summary materials. We can be a strategic partner to identify opportunities, implementing and evaluating educational programs designed to improve patient outcomes and manage cost.

Symposia for Clinicians

Alosa designs and delivers customized educational symposia—both in-person and virtual—tailored to the specific needs of our partners and their outpatient clinicians. Our expert physician advisors develop and present evidence-based, commercial-free content on requested topics. These symposia ensure clinicians receive the most current, relevant information to support high-quality patient care.